S. Jan de Beur

发表

Genetic Basis for Resistance to Parathyroid Hormone

M. Levine, E. Germain-Lee, S. Jan de Beur, 2003, Hormone Research in Paediatrics.

Diabetic serum from older women increases adipogenic differentiation in mesenchymal stem cells

K. F. Moseley, M. Doyle, S. Jan de Beur, 2018, Endocrine research.

Lean mass predicts hip geometry in men and women with non-insulin-requiring type 2 diabetes mellitus.

K. F. Moseley, D. Sellmeyer, K. Stewart, 2011, Journal of clinical densitometry : the official journal of the International Society for Clinical Densitometry.

Injury‐Activated Transforming Growth Factor β Controls Mobilization of Mesenchymal Stem Cells for Tissue Remodeling

X. Jia, K. Jiao, Xu Cao, 2012, Stem cells.

Continued Beneficial Effects of Burosumab in Adults with X-Linked Hypophosphatemia: Results from a 24-Week Treatment Continuation Period After a 24-Week Double-Blind Placebo-Controlled Period

R. Eastell, J. S. San Martin, S. Ralston, 2019, Calcified Tissue International.

Growth hormone deficiency in pseudohypoparathyroidism type 1a: another manifestation of multihormone resistance.

M. Levine, E. Germain-Lee, J. Groman, 2003, The Journal of clinical endocrinology and metabolism.

Goal‐Directed Treatment for Osteoporosis: A Progress Report From the ASBMR‐NOF Working Group on Goal‐Directed Treatment for Osteoporosis

D. Kiel, S. Cummings, C. Cooper, 2017, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

Fibroblast Growth Factor 23-Mediated Bone Disease.

A. Gonciulea, S. Jan de Beur, 2017, Endocrinology and metabolism clinics of North America.

Burosumab treatment in adults with X-linked hypophosphataemia: 96-week patient-reported outcomes and ambulatory function from a randomised phase 3 trial and open-label extension

R. Eastell, S. Ralston, M. Brandi, 2021, RMD Open.

High-Throughput Molecular Analysis of Pseudohypoparathyroidism 1b Patients Reveals Novel Genetic and Epigenetic Defects.

J. Danzig, M. Levine, Dong Li, 2021, The Journal of clinical endocrinology and metabolism.

Discordance between genetic and epigenetic defects in pseudohypoparathyroidism type 1b revealed by inconsistent loss of maternal imprinting at GNAS1.

A. Maret, C. Ding, M. Levine, 2003, American journal of human genetics.

Frequent derepression of G6PD and HPRT on the marsupial inactive X chromosome associated with cell proliferation in vitro.

B. Migeon, J. Axelman, S. Jan de Beur, 1989, Experimental cell research.

Paternally inherited inactivating mutations of the GNAS1 gene in progressive osseous heteroplasia.

M. Zasloff, M. Whyte, Jaimo Ahn, 2002, The New England journal of medicine.

Deficiency of the α‐Subunit of the Stimulatory G Protein and Severe Extraskeletal Ossification

W. Mcalister, M. Whyte, S. Yandow, 2000 .

The skeleton: Endocrine regulator of phosphate homeostasis

M. Doyle, S. Jan de Beur, 2008, Current osteoporosis reports.

A clinician's guide to X‐linked hypophosphatemia

I. Holm, K. Insogna, T. Carpenter, 2011, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

A Randomized, Double‐Blind, Placebo‐Controlled, Phase 3 Trial Evaluating the Efficacy of Burosumab, an Anti‐FGF23 Antibody, in Adults With X‐Linked Hypophosphatemia: Week 24 Primary Analysis

J. S. San Martin, R. Lachmann, H. Cheong, 2018, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

Postoperative hypoparathyroidism: medical and surgical therapeutic options.

S. Jan de Beur, V. Walker Harris, Vanessa Walker Harris, 2009, Thyroid : official journal of the American Thyroid Association.

Vitamin D-Binding Protein Deficiency and Homozygous Deletion of the GC Gene.

A. Baer, S. Jan de Beur, 2019, The New England journal of medicine.

Selection against lethal alleles in females heterozygous for incontinentia pigmenti.

B. Migeon, J. Axelman, G. Mitchell, 1989, American journal of human genetics.

Efficacy of Burosumab in Adults with X-linked Hypophosphatemia (XLH): A Post Hoc Subgroup Analysis of a Randomized Double-Blind Placebo-Controlled Phase 3 Study

R. Eastell, S. Ralston, M. Brandi, 2022, Calcified Tissue International.

Molecular pathogenesis of hypophosphatemic rickets.

M. Levine, S. Jan de Beur, 2002, The Journal of clinical endocrinology and metabolism.

Challenges in the management of tumor-induced osteomalacia (TIO).

P. Houillier, M. Brandi, S. Minisola, 2021, Bone.

Tumor-induced osteomalacia.

S. Jan de Beur, 2005, JAMA.

Consumptive hypothyroidism caused by paraneoplastic production of type 3 iodothyronine deiodinase.

Stephen A. Huang, S. Jan de Beur, M. Ruppe, 2005, Thyroid : official journal of the American Thyroid Association.

Reply to: Burosumab for Tumor‐Induced Osteomalacia: not Enough of a Good Thing

R. Kumar, F. Rauch, P. Miller, 2021, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

Burosumab for the Treatment of Tumor‐Induced Osteomalacia

R. Kumar, F. Rauch, P. Miller, 2020, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

Madelung-like deformity in pseudohypoparathyroidism type 1b.

G. Berkovitz, C. Ding, M. Levine, 2011, The Journal of clinical endocrinology and metabolism.

Deficiency of the alpha-subunit of the stimulatory G protein and severe extraskeletal ossification.

W. Mcalister, M. Whyte, S. Yandow, 2000, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

A case of renal osteodystrophy with unexpected serum intact parathyroid hormone concentrations.

L. Sokoll, D. Meany, S. Jan de Beur, 2009, Clinical chemistry.

Most Osteomalacia-associated Mesenchymal Tumors Are a Single Histopathologic Entity: An Analysis of 32 Cases and a Comprehensive Review of the Literature

E. Montgomery, A. Folpe, J. O'Connell, 2004, The American journal of surgical pathology.

Secreted frizzled-related protein 4 is a potent tumor-derived phosphaturic agent.

T. Craig, R. Kumar, T. Berndt, 2003, The Journal of clinical investigation.

FGF-23 inhibits renal tubular phosphate transport and is a PHEX substrate.

R. Kumar, R. Kumar, M. Levine, 2001, Biochemical and biophysical research communications.

The Pseudohypoparathyroidism Type 1b Locus Is Linked to a Region Including GNAS1 at 20q13.3

M. Levine, R. Peila, S. Jan de Beur, 2003, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

Pseudohypoparathyroidism 1b: exclusion of parathyroid hormone and its receptors as candidate disease genes.

T. Usdin, M. Labuda, C. Ding, 2000, The Journal of clinical endocrinology and metabolism.

The clinical diagnosis of osteoporosis: a position statement from the National Bone Health Alliance Working Group

S. Silverman, N. Watts, S. Khosla, 2014, Osteoporosis International.

Global guidance for the recognition, diagnosis, and management of tumor‐induced osteomalacia

P. Houillier, M. Brandi, J. Body, 2022, Journal of internal medicine.

Exercise effects on bone mineral density relationships to changes in fitness and fatness.

P. Hees, P. Ouyang, K. Stewart, 2005, American journal of preventive medicine.

Vaccination for Coronavirus Disease 2019 (COVID‐19) and Relationship to Osteoporosis Care: Current Evidence and Suggested Approaches

E. Yu, M. Drake, E. Tsourdi, 2021, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

Continued Beneficial Effects of Burosumab in Adults with X-Linked Hypophosphatemia: Results from a 24-Week Treatment Continuation Period After a 24-Week Double-Blind Placebo-Controlled Period

R. Eastell, J. S. San Martin, S. Ralston, 2019, Calcified Tissue International.